share_log

Brokers Set Expectations for Apollo Medical Holdings, Inc.'s Q3 2022 Earnings (NASDAQ:AMEH)

Brokers Set Expectations for Apollo Medical Holdings, Inc.'s Q3 2022 Earnings (NASDAQ:AMEH)

經紀商對阿波羅醫療控股公司2022年第三季度收益設定預期(納斯達克代碼:AMEH)
Defense World ·  2022/09/24 01:11

Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) – Equities researchers at William Blair issued their Q3 2022 earnings estimates for shares of Apollo Medical in a research note issued to investors on Wednesday, September 21st. William Blair analyst R. Daniels anticipates that the company will post earnings per share of $0.20 for the quarter. William Blair currently has a "Outperform" rating on the stock. William Blair also issued estimates for Apollo Medical's Q4 2022 earnings at $0.26 EPS, FY2022 earnings at $1.02 EPS, FY2023 earnings at $1.18 EPS, FY2024 earnings at $1.44 EPS and FY2025 earnings at $1.91 EPS.

阿波羅醫療控股公司(納斯達克代碼:AMEH-GET Rating)-威廉·布萊爾的股票研究員在9月21日星期三發給投資者的一份研究報告中發佈了他們對阿波羅醫療公司股票2022年第三季度收益的預期。威廉·布萊爾分析師R.Daniels預計,該公司本季度每股收益將達到0.20美元。威廉·布萊爾目前對該股的評級為“跑贏大盤”。威廉·布萊爾還發布了對阿波羅醫療公司2022財年第四季度每股收益0.26美元、2022財年每股收益1.02美元、2023財年每股收益1.18美元、2024財年每股收益1.44美元和2025財年每股收益1.91美元的預期。

Get
到達
Apollo Medical
阿波羅醫療
alerts:
警報:

Separately, Barclays lifted their target price on shares of Apollo Medical from $50.00 to $57.00 and gave the stock an "equal weight" rating in a research note on Monday, August 8th.

另外,巴克萊在8月8日週一的一份研究報告中將阿波羅醫療公司的股票目標價從50.00美元上調至57.00美元,並給予該股“同等權重”的評級。

Apollo Medical Stock Up 1.3 %

阿波羅醫療類股上漲1.3%

NASDAQ:AMEH opened at $41.09 on Friday. Apollo Medical has a fifty-two week low of $29.52 and a fifty-two week high of $133.23. The stock has a market capitalization of $2.32 billion, a P/E ratio of 25.68 and a beta of 0.75. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.49 and a current ratio of 2.49. The company's 50-day simple moving average is $46.62 and its 200-day simple moving average is $42.49.
納斯達克:AMEH上週五開盤報41.09美元。阿波羅醫療公司股價為52周低點29.52美元,52周高點133.23美元。該股市值為23.2億美元,市盈率為25.68倍,貝塔係數為0.75。該公司的負債權益比率為0.41,速動比率為2.49,流動比率為2.49。該公司50日簡單移動均線切入位在46.62美元,200日簡單移動均線切入位在42.49美元。

Hedge Funds Weigh In On Apollo Medical

對衝基金參與阿波羅醫療

Institutional investors have recently bought and sold shares of the business. Legal & General Group Plc increased its holdings in shares of Apollo Medical by 2.7% during the 2nd quarter. Legal & General Group Plc now owns 92,916 shares of the company's stock valued at $3,586,000 after purchasing an additional 2,408 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in Apollo Medical by 21.8% in the 2nd quarter. Thrivent Financial for Lutherans now owns 37,445 shares of the company's stock worth $1,445,000 after acquiring an additional 6,695 shares in the last quarter. AQR Capital Management LLC raised its position in Apollo Medical by 26.7% during the second quarter. AQR Capital Management LLC now owns 8,129 shares of the company's stock worth $314,000 after acquiring an additional 1,713 shares during the period. State Street Corp raised its position in Apollo Medical by 4.3% during the second quarter. State Street Corp now owns 1,276,787 shares of the company's stock worth $49,271,000 after acquiring an additional 52,716 shares during the period. Finally, Cubist Systematic Strategies LLC raised its position in shares of Apollo Medical by 199.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 16,386 shares of the company's stock worth $632,000 after purchasing an additional 10,920 shares during the last quarter. 32.03% of the stock is owned by hedge funds and other institutional investors.

機構投資者最近買賣了該公司的股票。Legal&General Group Plc在第二季度增持了2.7%的阿波羅醫療股份。Legal&General Group Plc現在擁有92,916股該公司股票,價值3,586,000美元,上個季度又購買了2,408股。路德會的ThriventFinancial在第二季度增持了21.8%的阿波羅醫療股份。在上個季度增持了6695股後,ThriventFinancial for Lutherans現在擁有37,445股該公司股票,價值1,445,000美元。AQR Capital Management LLC在第二季度將其在阿波羅醫療公司的持倉提高了26.7%。AQR Capital Management LLC在此期間額外收購了1,713股,目前擁有8,129股該公司股票,價值314,000美元。道富集團在第二季度將其在阿波羅醫療公司的持倉提高了4.3%。道富銀行目前持有該公司1,276,787股股票,價值49,271,000美元,在此期間又收購了52,716股。最後,立體主義系統戰略有限責任公司在第二季度將其在阿波羅醫療公司的股票頭寸提高了199.8%。Cubist Systems Strategy LLC在上個季度額外購買了10,920股後,現在擁有16,386股該公司股票,價值632,000美元。32.03%的股票由對衝基金和其他機構投資者持有。

About Apollo Medical

關於阿波羅醫療

(Get Rating)

(獲取評級)

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

阿波羅醫療控股公司是一家以醫生為中心、以技術為動力的醫療保健公司,提供醫療保健服務。該公司正在利用其專有的人口健康管理和醫療保健提供平臺,運營着一種集成的、基於價值的醫療保健模式,使其網絡中的提供者能夠為其患者提供護理。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Apollo Medical (AMEH)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • 2 Semiconductor Stocks To Watch For Reversals
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • 免費獲取StockNews.com關於阿波羅醫學(AMEH)的研究報告
  • MarketBeat:回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性?
  • 需要關注的2只半導體類股走勢逆轉
  • 小盤股的裁員是樓市的晴雨表嗎?
  • 好市多盈利後價格疲軟是買入的好時機嗎?

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《阿波羅醫學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對阿波羅醫療及相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論